NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,815 | -91.6% | 1,165 | -68.8% | 0.00% | -100.0% |
| Q1 2023 | $224,262 | -39.9% | 3,729 | -26.7% | 0.01% | -37.5% |
| Q4 2022 | $373,352 | -63.0% | 5,090 | -61.7% | 0.01% | -61.9% |
| Q3 2022 | $1,010,000 | +7.1% | 13,293 | -2.0% | 0.02% | +16.7% |
| Q2 2022 | $943,000 | -17.9% | 13,571 | -2.0% | 0.02% | 0.0% |
| Q1 2022 | $1,148,000 | -42.3% | 13,851 | -47.8% | 0.02% | -35.7% |
| Q4 2021 | $1,991,000 | -43.0% | 26,516 | -11.9% | 0.03% | -47.2% |
| Q3 2021 | $3,496,000 | -56.3% | 30,092 | -16.6% | 0.05% | -55.1% |
| Q2 2021 | $8,000,000 | +57.2% | 36,066 | -6.3% | 0.12% | +49.4% |
| Q1 2021 | $5,089,000 | -30.3% | 38,500 | -8.8% | 0.08% | -34.7% |
| Q4 2020 | $7,303,000 | +52.5% | 42,202 | -1.9% | 0.12% | +36.0% |
| Q3 2020 | $4,790,000 | +48.6% | 43,033 | -20.9% | 0.09% | +41.3% |
| Q2 2020 | $3,224,000 | -29.6% | 54,372 | -20.0% | 0.06% | -42.2% |
| Q1 2020 | $4,577,000 | -17.7% | 67,975 | +3.0% | 0.11% | +11.2% |
| Q4 2019 | $5,563,000 | -5.6% | 66,012 | -16.2% | 0.10% | -9.3% |
| Q3 2019 | $5,890,000 | +20.8% | 78,770 | +2.1% | 0.11% | +22.7% |
| Q2 2019 | $4,877,000 | +40.6% | 77,136 | +7.1% | 0.09% | +41.9% |
| Q1 2019 | $3,469,000 | +76.0% | 72,021 | +22.4% | 0.06% | +55.0% |
| Q4 2018 | $1,971,000 | -7.1% | 58,861 | +45.4% | 0.04% | +14.3% |
| Q3 2018 | $2,121,000 | +481.1% | 40,478 | +247.4% | 0.04% | +483.3% |
| Q2 2018 | $365,000 | – | 11,653 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |